281 related articles for article (PubMed ID: 8528401)
1. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
2. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
3. Parameters to enhance human hybridoma formation with hypoosmolar electrofusion.
Perkins S; Zimmermann U; Foung SK
Hum Antibodies Hybridomas; 1991 Jul; 2(3):155-9. PubMed ID: 1651789
[TBL] [Abstract][Full Text] [Related]
4. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
Foung SK; Engleman EG; Grumet FC
Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
[No Abstract] [Full Text] [Related]
5. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
Nemerow GR; McNaughton ME; Cooper NR
Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
[No Abstract] [Full Text] [Related]
6. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
Gore MM; Singhania SS; Basu A; Banerjee K
Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
[TBL] [Abstract][Full Text] [Related]
7. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
Denis KA; Wall R; Saxon A
J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
[TBL] [Abstract][Full Text] [Related]
8. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
9. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
10. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
11. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
12. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
13. Analysis of human antibody response to cholera vaccination by Epstein Barr virus transformation and human-human hybridoma production.
Ghosh S; Cannon CA; Campbell AM
J Clin Lab Immunol; 1987 Jul; 23(3):129-33. PubMed ID: 2444705
[TBL] [Abstract][Full Text] [Related]
14. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Yu X; McGraw PA; House FS; Crowe JE
J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
[TBL] [Abstract][Full Text] [Related]
15. [Production of human monoclonal antibodies by Epstein-Barr virus-transformed cell lines].
Avital A; Steinitz M
Harefuah; 1984 Oct; 107(7-8):167-8. PubMed ID: 6097516
[No Abstract] [Full Text] [Related]
16. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
17. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
18. The EBV-hybridoma technique.
Roder JC; Cole SP; Kozbor D
Methods Enzymol; 1986; 121():140-67. PubMed ID: 3014265
[No Abstract] [Full Text] [Related]
19. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
Panova I; Gustafsson B
Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
[TBL] [Abstract][Full Text] [Related]
20. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]